Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors

T Yin, Y Li, Y Ying, Z Luo - BMC infectious diseases, 2021 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is an infectious disease
characterized by cough, fever, and fatigue and 20% of cases will develop into severe …

Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis

S Cheng, Y Zhao, F Wang, Y Chen, AC Kaminga, H Xu - Medicine, 2021 - journals.lww.com
Background: An ongoing outbreak of pneumonia associated with the severe acute
respiratory coronavirus (SARS-CoV-2) emerged in December 2019 in Wuhan, China …

[HTML][HTML] Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

J Yang, YA Zheng, X Gou, K Pu, Z Chen, Q Guo… - International journal of …, 2020 - Elsevier
Background An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan,
China; the epidemic is more widespread than initially estimated, with cases now confirmed …

[HTML][HTML] Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

Y Zhou, Q Yang, J Chi, B Dong, W Lv, L Shen… - International Journal of …, 2020 - Elsevier
Objectives Existing findings regarding the relationship between comorbidities and the
severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim …

[PDF][PDF] Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis

J Yang, Y Zheng, X Gou, K Pu, Z Chen, Q Guo… - Int J Infect …, 2020 - medicinainterna.net.pe
Background: An outbreak of Novel Coronavirus (COVID-19) in Wuhan, China, the epidemic
is more widespread than initially estimated, with cases now confirmed in multiple countries …

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain, MJ Santana - American journal of …, 2021 - Elsevier
Introduction On February 11, 2020 WHO designated the name “COVID-19” for the disease
caused by “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), a novel virus …

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

W Guan, W Liang, Y Zhao, H Liang… - European …, 2020 - Eur Respiratory Soc
Background The coronavirus disease 2019 (COVID-19) outbreak is evolving rapidly
worldwide. Objective To evaluate the risk of serious adverse outcomes in patients with …

COVID-19 and comorbidities: a systematic review and meta-analysis

MS Gold, D Sehayek, S Gabrielli, X Zhang… - Postgraduate …, 2020 - Taylor & Francis
ABSTRACT SARS-CoV-2 has caused a worldwide pandemic that began with an outbreak of
pneumonia cases in the Hubei province of China. Knowledge of those most at risk is integral …

Impact of comorbidities on patients with COVID‐19: A large retrospective study in Zhejiang, China

C Ye, S Zhang, X Zhang, H Cai, J Gu… - Journal of medical …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) has become a serious public health
problem worldwide. Here, we stratified COVID‐19 patients based on their comorbidities to …

[HTML][HTML] COVID-19 and comorbidities: Deleterious impact on infected patients

H Ejaz, A Alsrhani, A Zafar, H Javed, K Junaid… - Journal of infection and …, 2020 - Elsevier
The pandemic situation with the emergence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …